Image guided gene therapy with modified stem cells: local delivery, tracking of labeled cells, and control of expression with local hyperthermia

Informazioni relative al progetto

BOS, CLEMENS

ID dell’accordo di sovvenzione: QLG1-CT-2002-51536

Data di avvio 1 Gennaio 2003

Data di completamento 31 Dicembre 2004

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 125 550,00

Contributo UE € 125 550,00

Coordinato da

UNIVERSITE VICTOR SEGALEN - BORDEAUX II
France

Obiettivo

Adult stem cells will be transfected and labelled with MRI contrast agents for tracking of the cells towards the target. Transgene expression will be controlled by MRI guided hyperthermia and the heat-sensitive hsp70 promoter.

Campo scientifico

• medical and health sciences › medical biotechnology › genetic engineering › gene therapy
• medical and health sciences › medical biotechnology › cells technologies › stem cells

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

RGI - Research grants (individual fellowships)

Coordinatore

UNIVERSITE VICTOR SEGALEN - BORDEAUX II

• Contributo UE: Nessun dato
• Indirizzo: Rue Léo-Saignat 146, Case 93 ; 33076 BORDEAUX ; Francia
• Costo totale: Nessun dato